Skip to main navigation Skip to search Skip to main content

Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease

  • Queen Ingrids Hospital
  • Nordland Hospital
  • University of Southern Denmark
  • Ilisimatusarfik Grønlands Universitet, Enhed for Læring og Udvikling
  • University of Nordland,

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is globally increasing in frequency and is expected to be the third largest cause of death by 2020. Smoking is the main risk factor of developing COPD. In Greenland, more than half of the adult population are daily smokers, and COPD may be common. International guidelines recommend the usage of spirometry as a golden standard for diagnosing COPD. The current number of spirometries performed among patients treated with medication targeting obstructive pulmonary disease in Greenland remains unexplored.

OBJECTIVE: To estimate the prevalence of patients aged 50 years or above treated with medication targeting obstructive pulmonary disease and the extent to which spirometry was performed among them within 2 years.

DESIGN: An observational, cross-sectional study based on the review of data obtained from electronic medical records in Greenland was performed. The inclusion criterion was that patients must have been permanent residents aged 50 years or above who had medication targeting obstructive pulmonary disease prescribed within a period of 15 months prior to data extraction. A full review of electronic patient records was done on each of the identified users of medication targeting obstructive pulmonary disease. Information on age, gender, town and spirometry was registered for each patient within the period from October 2013 to October 2015.

RESULTS: The prevalence of patients treated with medication targeting obstructive pulmonary disease aged 50 years or above was 7.9%. Of those, 34.8% had spirometry performed within 2 years and 50% had a forced expiratory volume (1 sec)/ forced vital capacity (FEV1/FVC) under 70% indicating obstructive pulmonary disease.

CONCLUSION: The use of medication targeting obstructive pulmonary disease among patients over 50 years old is common in Greenland. About one third of the patients had a spirometry performed within 2 years. To further increase spirometry performance, it is recommended to explore possible barriers in health care professionals' usage of spirometry in different health care settings in Greenland.

Original languageEnglish
Article number33258
JournalInternational Journal of Circumpolar Health
Volume75
Issue number1
Pages (from-to)33258
ISSN1239-9736
DOIs
Publication statusPublished - 8 Dec 2016
Externally publishedYes

Keywords

  • Age Factors
  • Aged
  • Cross-Sectional Studies
  • Electronic Health Records/statistics & numerical data
  • Female
  • Forced Expiratory Volume
  • Greenland/epidemiology
  • Humans
  • Lung Diseases, Obstructive/diagnosis
  • Male
  • Middle Aged
  • Prevalence
  • Primary Health Care
  • Registries
  • Spirometry

Fingerprint

Dive into the research topics of 'Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this